Comparative evaluation of PRP with nutritional supplements in improvement of hair loss in patients recovered from COVID-19

Not Applicable

Recruiting

Conditions: telogen effluvium.
Telogen effluvium
L65.0

Registration Number: IRCT20220603055066N1

Lead Sponsor: Bam University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 60

Inclusion Criteria

Age 20 to 50 years
Covid 19 disease (positive by PCR test) 2 to 4 months before enrollment
Occurrence of persistent and significant hair loss after Covid 19 disease, which according to the diagnosis of a dermatologist has a pattern similar to telogen effluvium

Exclusion Criteria

People who are diagnosed as the other types of alopecia (except telogen effluvium)
Pregnant or lactating women
Patients who are being treated with drugs such as finasteride, spironolactone, minoxidil or OCP or who have recently stopped taking these drugs
Patients who have an underlying disease affecting hair loss
Lack of informed consent to enter the study

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The amount of hair loss. Timepoint: The beginning of the study , 21 , 42 , 63. Method of measurement: Hair pull test.;The level of satisfaction of the state of hair loss, increased hair growth and hair quality. Timepoint: The beginning of the study , 21 , 42 , 63. Method of measurement: The satisfaction questionnaire is based on the examination of hair loss before and after the intervention, as well as the satisfaction level regarding the state of hair loss, increased hair growth and hair quality based on a five-point scale from very dissatisfied, which means a score of 0, to very satisfied, which means a score of 5. .

Secondary Outcome Measures